Trial Profile
Comparison of Tianeptine Versus Escitalopram for the Treatment of Depression and Cognitive Impairment in Patients With Major Depressive Disorder: A Randomized, Multicenter, Open-label Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Tianeptine (Primary) ; Escitalopram
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms CAMPION
- 12 Feb 2014 Results published in the Journal of Clinical Psychopharmacology.
- 12 Mar 2011 New trial record